Skip to main navigation Skip to search Skip to main content

Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level

  • Valérie Boige
  • , Julien Taïeb
  • , Mohamed Hebbar
  • , David Malka
  • , Thierry Debaere
  • , Laurent Hannoun
  • , Emmanuelle Magherini
  • , Dominique Mignard
  • , Thierry Poynard
  • , Michel Ducreux
  • Institut Gustave Roussy
  • Sorbonne Université
  • CHRU Roger Salengro
  • Sanofi-Aventis

Research output: Contribution to journal › Article › peer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science